title: Protracted herpes zoster and severe postherpetic neuralgia after inadvertant infliximab administration.
authors.forename: Valérie
authors.initials: V
authors.lastname: Failla
authors.forename: Charlotte
authors.initials: C
authors.lastname: Castronovo
authors.forename: Cécile
authors.initials: C
authors.lastname: Meex
authors.forename: Arjen F
authors.initials: AF
authors.lastname: Nikkels
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives; D000284:Administration, Oral; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage; D003424:Crohn Disease / Q000188:drug therapy; D005260:Female; D006562:Herpes Zoster / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D051474:Neuralgia, Postherpetic / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir